NEW YORK (GenomeWeb News) — Merck today said that its acquisition of RNAi shop Sirna Therapeutics may close as early as this month.
Merck announced its plans to acquire Sirna for $1.1 billion in cash on Oct. 30. At the time, the company said it expected the deal to close by the first quarter of 2007.
Today Merck said it expects the deal to close “in late December 2006 or early in the first quarter of 2007.”
The acquisition must still be approved by Sirna's shareholders and other conditions. Sirna shareholders are expected to vote on the deal on Dec. 28.